T
Teresa M. Lavacca
Researcher at Technische Universität München
Publications - 5
Citations - 781
Teresa M. Lavacca is an academic researcher from Technische Universität München. The author has contributed to research in topics: Proteomics & Proteome. The author has an hindex of 3, co-authored 4 publications receiving 318 citations.
Papers
More filters
Journal ArticleDOI
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Alexey Stukalov,Virginie Girault,Vincent Grass,Ozge Karayel,Valter Bergant,Christian Urban,Darya A. Haas,Yiqi Huang,Lila Oubraham,Anqi Wang,M. Sabri Hamad,Antonio Piras,Fynn M. Hansen,Maria C. Tanzer,Igor Paron,Luca Zinzula,Thomas Engleitner,Maria Reinecke,Maria Reinecke,Teresa M. Lavacca,Rosina Ehmann,Roman Wölfel,Jörg Jores,Bernhard Kuster,Bernhard Kuster,Ulrike Protzer,Roland Rad,John Ziebuhr,Volker Thiel,Pietro Scaturro,Pietro Scaturro,Matthias Mann,Andreas Pichlmair +32 more
TL;DR: A concurrent multi-omics study of SARS CoV-2 and SARS-CoV was conducted in this article, where the authors profiled the interactomes of both viruses, as well as their influence on the transcriptome, proteome, ubiquitinome and phosphoproteome of a lung derived human cell line.
Posted ContentDOI
Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV
Alexey Stukalov,Virginie Girault,Vincent Grass,Ozge Karayel,Valter Bergant,Christian Urban,Darya A. Haas,Yiqi Huang,Lila Oubraham,Anqi Wang,Sabri M. Hamad,Antonio Piras,Fynn M. Hansen,Maria C. Tanzer,Igor Paron,Luca Zinzula,Luca Zinzula,Thomas Engleitner,Maria Reinecke,Maria Reinecke,Teresa M. Lavacca,Rosina Ehmann,Roman Wölfel,Jörg Jores,Bernhard Kuster,Bernhard Kuster,Ulrike Protzer,Roland Rad,John Ziebuhr,Volker Thiel,Pietro Scaturro,Pietro Scaturro,Matthias Mann,Andreas Pichlmair +33 more
TL;DR: The TGF-β pathway, known for its involvement in tissue fibrosis, was specifically dysregulated by Sars-CoV-2 ORF8 and autophagy by SARS-CoVs ORF3, and was identified as a hotspot that can be targeted by existing drugs and it can guide rational design of virus- and host-directed therapies.
Posted ContentDOI
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Alexey Stukalov,Virginie Girault,Vincent Grass,Ozge Karayel,Valter Bergant,Christian Urban,Darya A. Haas,Yiqi Huang,Lila Oubraham,Anqi Wang,M. Sabri Hamad,Antonio Piras,Fynn M. Hansen,Maria C. Tanzer,Igor Paron,Luca Zinzula,Thomas Enghleitner,Maria Reinecke,Maria Reinecke,Teresa M. Lavacca,Rosina Ehmann,Roman Wölfel,Jörg Jores,Bernhard Kuster,Bernhard Kuster,Ulrike Protzer,Roland Rad,John Ziebuhr,Volker Thiel,Pietro Scaturro,Pietro Scaturro,Matthias Mann,Andreas Pichlmair +32 more
TL;DR: In this paper, the authors conducted a concurrent multi-omics study of SARS-CoV-2 and SARS CoV, and profiled the interactome of both viruses, as well as their influence on transcriptome, proteome, ubiquitinome and phosphoproteome in a lung-derived human cell line.
Journal ArticleDOI
Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulators.
Friederike L. Pennemann,Assel Mussabekova,Christian Urban,Alexey Stukalov,Line Lykke Andersen,Vincent Grass,Teresa M. Lavacca,Cathleen Holze,Lila Oubraham,Yasmine Benamrouche,Enrico Girardi,Rasha E. Boulos,Rune Hartmann,Giulio Superti-Furga,Giulio Superti-Furga,Matthias Habjan,Jean-Luc Imler,Carine Meignin,Andreas Pichlmair,Andreas Pichlmair +19 more
TL;DR: This paper used an affinity proteomics approach in evolutionary distant species (human, mouse and fly) to identify proteins that are conserved in their ability to associate with diverse viral nucleic acids.
Journal ArticleDOI
Attenuation of SARS‐CoV‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases
Valter Bergant,Shintaro Yamada,Vincent Grass,Yuta Tsukamoto,Teresa M. Lavacca,Karsten Krey,Maria-Teresa Mühlhofer,Sabine Wittmann,Armin Ensser,Alexandra Herrmann,Anja vom Hemdt,Yuriko Tomita,Shutoku Matsuyama,Takatsugu Hirokawa,Yiqi Huang,Antonio Piras,Constanze A. Jakwerth,Madlene Oelsner,Susanne E. Thieme,Alexander Graf,Stefan Krebs,Helmut Blum,Beate M. Kümmerer,Alexey Stukalov,Carsten B. Schmidt-Weber,Manabu Igarashi,Thomas Gramberg,Andreas Pichlmair,Hiroki Kato +28 more
TL;DR: It is found that the host cap 2'‐O‐ribose methyl transferase MTr1 can compensate for loss of viral NSP16 methyltransferase in facilitating virus replication, and multispecific and metabolic MTase inhibitors constitute yet unexplored treatment options against COVID‐19.